# ANO3

## Overview
ANO3 is a gene that encodes the protein anoctamin 3, which is a member of the anoctamin family of proteins, known for their role as calcium-activated chloride channels. Anoctamin 3 is characterized by its multiple transmembrane domains and is primarily involved in modulating neuronal excitability, particularly within the nervous system. Unlike other members of its family, anoctamin 3 does not form ion channels independently but instead enhances the activity of sodium-activated potassium channels, such as the Slack channel, thereby influencing neuronal signaling and excitability. This modulation is crucial in nociceptive neurons, where it helps regulate responses to pain stimuli. Additionally, mutations in the ANO3 gene have been linked to various forms of dystonia, highlighting its clinical significance in neuromuscular disorders (Benarroch2017Anoctamins; Pedemonte2014Structure; Charlesworth2012Mutations).

## Structure
The ANO3 gene encodes a protein that is part of the anoctamin family, which includes calcium-activated chloride channels. ANO3 is characterized by a sequence of amino acids that form its primary structure, and it is predicted to have multiple transmembrane domains. The protein is suggested to have a topology with eight transmembrane domains, with cytosolic NH2- and COOH-termini, and a reentrant loop between transmembrane domains 5 and 6, which may participate in ion selectivity (Duran2012ANOs; Pedemonte2014Structure).

The secondary structure of ANO3 likely includes alpha helices and beta sheets, typical of transmembrane proteins, although specific details are not provided in the context. The tertiary structure involves the 3D folding of these domains, but detailed structural data for ANO3 is not available. ANO3 does not form ion channels by itself but can enhance the activity of the Na+-activated K+ channel, Slack, suggesting a regulatory role rather than a direct channel function (Pedemonte2014Structure).

Post-translational modifications such as phosphorylation may occur, affecting its function and localization. Splice variant isoforms of ANO3 may exist, potentially influencing its physiological roles and interactions (Ran2019Anoctamin).

## Function
ANO3, also known as TMEM16C, is a protein that plays a significant role in modulating neuronal excitability, particularly in the nervous system. It is highly expressed in a subset of nociceptive neurons within the dorsal root ganglia (DRG) and is associated with sodium-activated potassium (Slack) channels. ANO3 enhances the activity of these channels, leading to increased potassium efflux, which reduces neuronal excitability and dampens the firing of action potentials in response to pain stimuli (Benarroch2017Anoctamins; Oh2016Cellular; Pedemonte2014Structure).

In healthy human cells, ANO3 does not form ion channels independently but modulates the function of Slack channels by increasing their sodium sensitivity and single-channel conductance. This interaction is crucial for regulating the excitability of nociceptive neurons, as it helps in hyperpolarizing the cell membrane when intracellular sodium concentrations rise due to prolonged action potentials (Pedemonte2014Structure). ANO3 is also expressed in the striatum and cerebral cortex, suggesting a broader role in neuronal signaling and excitability beyond nociception (Benarroch2017Anoctamins).

## Clinical Significance
Mutations in the ANO3 gene are associated with various forms of dystonia, particularly autosomal dominant craniocervical dystonia (DYT24). This condition is characterized by involuntary muscle contractions affecting the head and neck, often presenting as cervical dystonia and sometimes accompanied by laryngeal dystonia (Benarroch2017Anoctamins; Charlesworth2012Mutations). The age of onset for ANO3-related dystonia can range from early childhood to late adulthood, with symptoms including tremor, myoclonus, and in some cases, chorea and dysarthria (Li2020ANO3; Jiang2021The).

Pathogenic variants in ANO3 can lead to abnormal neuronal excitability, potentially resulting in dystonic movements and other hyperkinetic disorders (Blackburn2016A). These mutations are thought to disrupt calcium signaling within cells, as evidenced by studies showing reduced calcium signals in fibroblasts from affected individuals (Charlesworth2012Mutations). The phenotypic expression of ANO3 mutations is highly variable, with some individuals experiencing focal dystonia, while others may develop generalized dystonia or parkinsonism (Jiang2021The; Carvalho2021Another).

The clinical significance of ANO3 mutations underscores the importance of genetic screening in diagnosing and understanding the diverse presentations of dystonia (Charlesworth2012Mutations).

## Interactions
ANO3, also known as anoctamin 3, is involved in several protein interactions that influence its function in cellular processes. ANO3 is expressed in a subpopulation of nociceptive dorsal root ganglion (DRG) neurons, where it interacts with sodium-activated potassium (Slack) channels. This interaction enhances the activity of Slack channels, leading to increased potassium efflux and reduced neuronal excitability. This modulation of Slack channel activity by ANO3 is significant in nonpeptidergic isolectin B4-positive nociceptive DRG neurons, which are primarily mechanosensitive (Benarroch2017Anoctamins; Oh2016Cellular).

In addition to its role in nociception, ANO3 is implicated in calcium signaling pathways. Mutations in ANO3 have been associated with abnormalities in endoplasmic-reticulum-dependent calcium signaling, particularly in the context of craniocervical dystonia. These mutations can affect calcium homeostasis, as evidenced by reduced ATP-induced calcium signals in fibroblasts from affected individuals (Charlesworth2012Mutations). The interaction of ANO3 with calcium signaling pathways suggests its involvement in broader regulatory networks within the cell, although specific protein partners in these pathways are not detailed in the available context.


## References


[1. (Benarroch2017Anoctamins) Eduardo E. Benarroch. Anoctamins (tmem16 proteins): functions and involvement in neurologic disease. Neurology, 89(7):722–729, August 2017. URL: http://dx.doi.org/10.1212/WNL.0000000000004246, doi:10.1212/wnl.0000000000004246. This article has 27 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/WNL.0000000000004246)

[2. (Oh2016Cellular) Uhtaek Oh and Jooyoung Jung. Cellular functions of tmem16/anoctamin. Pflügers Archiv - European Journal of Physiology, 468(3):443–453, January 2016. URL: http://dx.doi.org/10.1007/s00424-016-1790-0, doi:10.1007/s00424-016-1790-0. This article has 140 citations.](https://doi.org/10.1007/s00424-016-1790-0)

[3. (Pedemonte2014Structure) Nicoletta Pedemonte and Luis J. V. Galietta. Structure and function of tmem16 proteins (anoctamins). Physiological Reviews, 94(2):419–459, April 2014. URL: http://dx.doi.org/10.1152/physrev.00039.2011, doi:10.1152/physrev.00039.2011. This article has 551 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00039.2011)

[4. (Duran2012ANOs) Charity Duran, Zhiqiang Qu, Adeboye O. Osunkoya, Yuanyuan Cui, and H. Criss Hartzell. Anos 3–7 in the anoctamin/tmem16 cl− channel family are intracellular proteins. American Journal of Physiology-Cell Physiology, 302(3):C482–C493, February 2012. URL: http://dx.doi.org/10.1152/ajpcell.00140.2011, doi:10.1152/ajpcell.00140.2011. This article has 106 citations.](https://doi.org/10.1152/ajpcell.00140.2011)

[5. (Li2020ANO3) Shanglin Li, Lin Wang, Yingmai Yang, Jun Ma, and Xinhua Wan. Ano3 mutations in chinese dystonia: a genetic screening study using next-generation sequencing. Frontiers in Neurology, February 2020. URL: http://dx.doi.org/10.3389/fneur.2019.01351, doi:10.3389/fneur.2019.01351. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2019.01351)

[6. (Ran2019Anoctamin) Caroline Ran, Carmen Fourier, Donia Arafa, Franziska Liesecke, Christina Sjöstrand, Elisabet Waldenlind, Anna Steinberg, and Andrea Belin. Anoctamin 3: a possible link between cluster headache and ca2+ signaling. Brain Sciences, 9(8):184, July 2019. URL: http://dx.doi.org/10.3390/brainsci9080184, doi:10.3390/brainsci9080184. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/brainsci9080184)

[7. (Jiang2021The) Li-Ting Jiang, Li-Xi Li, Ying Liu, Xiao-Long Zhang, You-Gui Pan, Lin Wang, Xin-Hua Wan, and Ling-Jing Jin. The expanding clinical and genetic spectrum of ano3 dystonia. Neuroscience Letters, 746:135590, February 2021. URL: http://dx.doi.org/10.1016/j.neulet.2020.135590, doi:10.1016/j.neulet.2020.135590. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neulet.2020.135590)

[8. (Blackburn2016A) Patrick R. Blackburn, Michael T. Zimmermann, Jennifer M. Gass, Kimberly G. Harris, Margot A. Cousin, Nicole J. Boczek, Owen A. Ross, Eric W. Klee, Paul W. Brazis, Jay A. Van Gerpen, and Paldeep S. Atwal. A novel ano3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics. BMC Medical Genetics, December 2016. URL: http://dx.doi.org/10.1186/s12881-016-0354-7, doi:10.1186/s12881-016-0354-7. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-016-0354-7)

[9. (Charlesworth2012Mutations) Gavin Charlesworth, Vincent Plagnol, Kira M. Holmström, Jose Bras, Una-Marie Sheerin, Elisavet Preza, Ignacio Rubio-Agusti, Mina Ryten, Susanne A. Schneider, Maria Stamelou, Daniah Trabzuni, Andrey Y. Abramov, Kailash P. Bhatia, and Nicholas W. Wood. Mutations in ano3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. The American Journal of Human Genetics, 91(6):1041–1050, December 2012. URL: http://dx.doi.org/10.1016/j.ajhg.2012.10.024, doi:10.1016/j.ajhg.2012.10.024. This article has 211 citations.](https://doi.org/10.1016/j.ajhg.2012.10.024)

[10. (Carvalho2021Another) Vanessa Carvalho, Joana Martins, Filipe Correia, Manuela Costa, João Massano, and Teresa Temudo. Another twist in the tale: intrafamilial phenotypic heterogeneity in <scp>ano3</scp>‐related dystonia. Movement Disorders Clinical Practice, 8(5):758–762, April 2021. URL: http://dx.doi.org/10.1002/mdc3.13209, doi:10.1002/mdc3.13209. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mdc3.13209)